Dry eye disease is a common condition that affects millions of people worldwide. It occurs when the eyes do not produce enough tears or when the tears evaporate too quickly. This can lead to discomfort, redness, and blurry vision. Many treatment options are available for dry eye disease, including eye drops, medications, and interventional procedures. In a recent study conducted by Sight Science..
Suono Bio Reports Encouraging Results From a First in Human (FiH) Study of Its Ultrasound Mediated Drug Delivery Platform In a recent study, Suono Bio Inc. has unveiled promising findings from its first clinical trial testing the SuonoCalm™ platform. This groundbreaking study demonstrates the feasibility and safety of using ultrasound for drug delivery in the gastrointestinal tract. The study co..
Harmony Biosciences, a pharmaceutical company focused on developing therapies for rare neurological diseases, has announced its plans to conduct a Phase 3 registrational study of pitolisant in individuals with Prader-Willi syndrome (PWS) who are experiencing excessive daytime sleepiness (EDS). This study will include children, adolescents, and adults with PWS. The decision to proceed with the st..
Promontory Therapeutics Inc., a clinical stage pharmaceutical company specializing in innovative treatments for cancer, has recently expanded its Phase 2 trial of PT-112 to include patients in France. This exciting development marks the company's first foray into the French market and brings hope to individuals with metastatic castrate-resistant prostate cancer (mCRPC). The trial, which is curre..
Vir Biotechnology has released the topline data from its Phase 2 PENINSULA trial, which evaluated VIR-2482 for the prevention of seasonal influenza A illness. According to the announcement made on July 20, 2023, VIR BIOTECHNOLOGY Inc. reported that the trial did not meet its primary or secondary efficacy endpoints. In participants who received the highest dose of VIR-2482 (1,200 mg), there was a..
23andMe Releases New FDA-Cleared Genetic Report on Simvastatin, a Commonly Prescribed Statin In an exciting development, 23andMe has become the first and only direct-to-consumer product to offer a suite of FDA-authorized pharmacogenetics reports, providing valuable medication insights. One such report focuses on simvastatin, a widely prescribed lipid-lowering statin. Genetics can significantly i..
